speaker-photo

Um Alkair

9:00 - 9:15

Day 2 Scientific Program – Day 2

De-escalation of Therapy in Early Breast Cancer: When Less Is More (Minimizing surgery, radiation, and systemic therapy while preserving outcomes) (Minimizing surgery, radiation, and systemic therapy while preserving outcomes)

9:15 - 9:30

Day 2 Scientific Program – Day 2

Multigene Assays in 2025: Refining Risk and Guiding Treatment (Oncotype DX, MammaPrint, and emerging genomic signatures)